These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 30799057)

  • 1. Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia.
    Wang E; Lu SX; Pastore A; Chen X; Imig J; Chun-Wei Lee S; Hockemeyer K; Ghebrechristos YE; Yoshimi A; Inoue D; Ki M; Cho H; Bitner L; Kloetgen A; Lin KT; Uehara T; Owa T; Tibes R; Krainer AR; Abdel-Wahab O; Aifantis I
    Cancer Cell; 2019 Mar; 35(3):369-384.e7. PubMed ID: 30799057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9.
    Zhang M; Hyle J; Chen X; Xin Y; Jin Y; Zhang J; Yang X; Chen X; Wright S; Liu Z; Rosikiewicz W; Xu B; He L; Liu H; Ping N; Wu D; Wen F; Li C; Xu P
    Genome Biol; 2024 Jan; 25(1):16. PubMed ID: 38216972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA-binding proteins as drivers of AML and novel therapeutic targets.
    Qin T; Cheng Y; Wang X
    Leuk Lymphoma; 2022 May; 63(5):1045-1057. PubMed ID: 35075986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multiplex CRISPR-Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AML.
    Hassan JJ; Lieske A; Dörpmund N; Klatt D; Hoffmann D; Kleppa MJ; Kustikova OS; Stahlhut M; Schwarzer A; Schambach A; Maetzig T
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502319
    [No Abstract]   [Full Text] [Related]  

  • 5. Distinct noncoding RNAs and RNA binding proteins associated with high-risk pediatric and adult acute myeloid leukemias detected by regulatory network analysis.
    Liu Z; Spiegelman VS; Wang HG
    Cancer Rep (Hoboken); 2022 Oct; 5(10):e1592. PubMed ID: 34862757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide identification of aberrant alternative splicing and RNA-binding protein regulators in acute myeloid leukaemia which may contribute to immune microenvironment remodelling.
    Yang Y; Zhang YM; Wang Y; Liu K; Cui SY; Luo YQ; Zheng W; Xu J; Duan W; Wang JY
    Carcinogenesis; 2023 Aug; 44(5):418-425. PubMed ID: 37209099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase separation-competent FBL promotes early pre-rRNA processing and translation in acute myeloid leukaemia.
    Yang L; Zhang Z; Jiang P; Kong D; Yu Z; Shi D; Han Y; Chen E; Zheng W; Sun J; Zhao Y; Luo Y; Shi J; Yao H; Huang H; Qian P
    Nat Cell Biol; 2024 Jun; 26(6):946-961. PubMed ID: 38745030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant U2AF1-Induced Mis-Splicing of mRNA Translation Genes Confers Resistance to Chemotherapy in Acute Myeloid Leukemia.
    Jin P; Wang X; Jin Q; Zhang Y; Shen J; Jiang G; Zhu H; Zhao M; Wang D; Li Z; Zhou Y; Li W; Zhang W; Liu Y; Wang S; Jin W; Cao Y; Sheng G; Dong F; Wu S; Li X; Jin Z; He M; Liu X; Chen L; Zhang Y; Wang K; Li J
    Cancer Res; 2024 May; 84(10):1583-1596. PubMed ID: 38417135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic alternative mRNA splicing signatures and associated splicing factors in acute myeloid leukemia.
    Jin P; Tan Y; Zhang W; Li J; Wang K
    Neoplasia; 2020 Sep; 22(9):447-457. PubMed ID: 32653835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vivo Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target.
    Vujovic A; de Rooij L; Chahi AK; Chen HT; Yee BA; Loganathan SK; Liu L; Chan DCH; Tajik A; Tsao E; Moreira S; Joshi P; Xu J; Wong N; Balde Z; Jahangiri S; Zandi S; Aigner S; Dick JE; Minden MD; Schramek D; Yeo GW; Hope KJ
    Blood Cancer Discov; 2023 May; 4(3):180-207. PubMed ID: 36763002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Alternative Splicing Events on Acute Myeloid Leukemia.
    Chen SL; Dai YJ; Hu F; Wang Y; Li H; Liang Y
    DNA Cell Biol; 2020 Nov; 39(11):2040-2051. PubMed ID: 32915082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting RBM39 through indisulam induced mis-splicing of mRNA to exert anti-cancer effects in T-cell acute lymphoblastic leukemia.
    Ji T; Yang Y; Yu J; Yin H; Chu X; Yang P; Xu L; Wang X; Hu S; Li Y; Wu X; Liu W; Zhou B; Wang W; Zhang S; Cheng W; Chen Y; Shi L; Li Z; Zhuo R; Zhang Y; Tao Y; Wu D; Li X; Zhang Z; Fan JJ; Pan J; Lu J
    J Exp Clin Cancer Res; 2024 Jul; 43(1):205. PubMed ID: 39044280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia.
    Zhou J; Bi C; Ching YQ; Chooi JY; Lu X; Quah JY; Toh SH; Chan ZL; Tan TZ; Chong PS; Chng WJ
    J Hematol Oncol; 2017 Jul; 10(1):138. PubMed ID: 28693523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PBX3 is essential for leukemia stem cell maintenance in MLL-rearranged leukemia.
    Guo H; Chu Y; Wang L; Chen X; Chen Y; Cheng H; Zhang L; Zhou Y; Yang FC; Cheng T; Xu M; Zhang X; Zhou J; Yuan W
    Int J Cancer; 2017 Jul; 141(2):324-335. PubMed ID: 28411381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner.
    Feng M; Xie X; Han G; Zhang T; Li Y; Li Y; Yin R; Wang Q; Zhang T; Wang P; Hu J; Cheng Y; Gao Z; Wang J; Chang J; Cui M; Gao K; Chai J; Liu W; Guo C; Li S; Liu L; Zhou F; Chen J; Zhang H
    Blood; 2021 Jul; 138(1):71-85. PubMed ID: 33763698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of CTCF Boundary at HOXA Locus Promote BET Inhibitors' Therapeutic Sensitivity in Acute Myeloid Leukemia.
    Zha J; Lai Q; Deng M; Shi P; Zhao H; Chen Q; Wu H; Xu B
    Stem Cell Rev Rep; 2020 Dec; 16(6):1280-1291. PubMed ID: 33057942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human PRPF40B regulates hundreds of alternative splicing targets and represses a hypoxia expression signature.
    Lorenzini PA; Chew RSE; Tan CW; Yong JY; Zhang F; Zheng J; Roca X
    RNA; 2019 Aug; 25(8):905-920. PubMed ID: 31088860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The EMT regulator ZEB2 is a novel dependency of human and murine acute myeloid leukemia.
    Li H; Mar BG; Zhang H; Puram RV; Vazquez F; Weir BA; Hahn WC; Ebert B; Pellman D
    Blood; 2017 Jan; 129(4):497-508. PubMed ID: 27756750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells.
    Vu LP; Prieto C; Amin EM; Chhangawala S; Krivtsov A; Calvo-Vidal MN; Chou T; Chow A; Minuesa G; Park SM; Barlowe TS; Taggart J; Tivnan P; Deering RP; Chu LP; Kwon JA; Meydan C; Perales-Paton J; Arshi A; Gönen M; Famulare C; Patel M; Paietta E; Tallman MS; Lu Y; Glass J; Garret-Bakelman FE; Melnick A; Levine R; Al-Shahrour F; Järås M; Hacohen N; Hwang A; Garippa R; Lengner CJ; Armstrong SA; Cerchietti L; Cowley GS; Root D; Doench J; Leslie C; Ebert BL; Kharas MG
    Nat Genet; 2017 Jun; 49(6):866-875. PubMed ID: 28436985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six1 regulates leukemia stem cell maintenance in acute myeloid leukemia.
    Chu Y; Chen Y; Li M; Shi D; Wang B; Lian Y; Cheng X; Wang X; Xu M; Cheng T; Shi J; Yuan W
    Cancer Sci; 2019 Jul; 110(7):2200-2210. PubMed ID: 31050834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.